10-Q/A

 
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  FORM 10-Q/A

           [X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                  THE SECURITIES EXCHANGE ACT OF 1934

           For the quarterly period ended March 31, 1995

                                       OR

           [ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                   THE SECURITIES EXCHANGE ACT OF 1934

           For the transition period from _______ to ______

                        Commission File Number 0-17822

                                 SYNETIC, INC.
            (Exact name of registrant as specified in its charter)


                  Delaware                              22-2975182
        (State or other jurisdiction of              (I.R.S Employer
        incorporation or organization)               Identification No.)


             River Drive Center 2
             669 River Drive
             Elmwood Park, New Jersey                     07407
        (Address of principal executive offices)       (Zip code)

        Registrant's telephone number, including area code:  (201) 703-3400

 
     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months, and (2) has been subject to such filing
requirements for the past 90 days.  Yes  X   No ___
                                        ---        

 
     Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.

      Class                             Outstanding at May 8,1995
- ---------------------                   -------------------------
Common Stock                            16,579,737 shares par value
$.01 per share

 
                         SYNETIC INC. AND SUBSIDIARIES


PART II.  OTHER INFORMATION

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.


     (a)  Exhibits

          Exhibit No.    Description

              27         Financial Data Schedule


     (b)  On January 27, 1995, the Company filed a report on Form 8-K presenting
          the consolidated financial statements of the Company, previously
          included in the Company's Annual Report on Form 10-K for the fiscal
          year ended June 30, 1994, restated to report separately the net assets
          and operating results of the discontinued operations of the
          institutional pharmacy business sold to Pharmacy Corporation of
          America, an indirect wholly owned subsidiary of Beverly Enterprises,
          Inc., on December 14, 1994.

                                       2

 
                                   SIGNATURE


          Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
 
                                    SYNETIC, INC.



                                    /s/ VICTOR L. MARRERO
                                    --------------------------------
                                    Victor L. Marrero
                                    Vice President - Finance
                                    and Chief Financial Officer



Dated: July 5, 1995


                                       3

 
                                 EXHIBIT INDEX


                       Number    Description

                         27      Financial Data Schedule

EX-27

 


 
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SYNETIC 
INC.'S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES 
EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1995 AND IS 
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1995
<PERIOD-START>                             JUL-01-1994
<PERIOD-END>                               MAR-31-1995
<CASH>                                           5,700
<SECURITIES>                                   140,760
<RECEIVABLES>                                    6,753
<ALLOWANCES>                                       492
<INVENTORY>                                      6,212
<CURRENT-ASSETS>                               113,421
<PP&E>                                          30,468
<DEPRECIATION>                                  13,719
<TOTAL-ASSETS>                                 180,216
<CURRENT-LIABILITIES>                           10,103
<BONDS>                                              0
<COMMON>                                           218
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     161,714
<TOTAL-LIABILITY-AND-EQUITY>                   180,216
<SALES>                                         28,288
<TOTAL-REVENUES>                                28,288
<CGS>                                           16,875
<TOTAL-COSTS>                                   16,875
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,603
<INCOME-PRETAX>                                (2,571)
<INCOME-TAX>                                     (970)
<INCOME-CONTINUING>                            (1,601)
<DISCONTINUED>                                  12,748
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,147
<EPS-PRIMARY>                                      .65
<EPS-DILUTED>                                        0